FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007347895> ?p ?o ?g. }

• W2007347895 endingPage "5161" @default.
• W2007347895 startingPage "5148" @default.
• W2007347895 abstract "High intensity focused ultrasound (HIFU) has attracted the great attention in tumor ablation due to its non-invasive, efficient and economic features. However, HIFU ablation has its intrinsic limitations for removing the residual tumor cells, thus the tumor recurrence and metastasis cannot be avoided in this case. Herein, we developed a multifunctional targeted poly(lactic-co-glycolic acid) (PLGA) nanobubbles (NBs), which not only function as an efficient ultrasound contrast agent for tumor imaging, but also a targeted anticancer drug carrier and excellent synergistic agent for enhancing the therapeutic efficiency of HIFU ablation. Methotrexate (MTX)-loaded NBs were synthesized and filled with perfluorocarbon gas subsequently using a facile but general double emulsion evaporation method. The active tumor-targeting monoclonal anti-HLA-G antibodies (mAbHLA-G) were further conjugated onto the surface of nanobubbles. The mAbHLA-G/MTX/PLGA NBs could enhance the ultrasound imaging both in vitro and in vivo, and the targeting efficiency to HLA-G overexpressing JEG-3 cells has been demonstrated. The elaborately designed mAbHLA-G/MTX/PLGA NBs can specifically target to the tumor cells both in vitro and in vivo, and their blood circulation time in vivo was much longer than non-targeted MTX/PLGA NBs. Further therapeutic evaluations showed that the targeted NBs as a synergistic agent can significantly improve the efficiency of HIFU ablation by changing the acoustic environment, and the focused ultrasound can promote the on-demand MTX release both in vitro and in vivo. The in vivo histopathology test and immunohistochemical analysis showed that the mAbHLA-G/MTX/PLGA NBs plus HIFU group presented most serious coagulative necrosis, the lowest proliferation index and the highest apoptotic index. Therefore, the successful introduction of targeted mAbHLA-G/MTX/PLGA NBs provides an excellent platform for the highly efficient, imaging-guided and non-invasive HIFU synergistic therapy of cancer with the supplementary functions of killing residual tumor cells and preventing tumor recurrence/metastasis." @default.
• W2007347895 created "2016-06-24" @default.
• W2007347895 creator A5006996556 @default.
• W2007347895 creator A5023209304 @default.
• W2007347895 creator A5025996303 @default.
• W2007347895 creator A5028584083 @default.
• W2007347895 creator A5033244066 @default.
• W2007347895 creator A5045109662 @default.
• W2007347895 creator A5051430265 @default.
• W2007347895 creator A5053798680 @default.
• W2007347895 creator A5060185042 @default.
• W2007347895 creator A5079540565 @default.
• W2007347895 creator A5083636323 @default.
• W2007347895 creator A5086874263 @default.
• W2007347895 creator A5090257305 @default.
• W2007347895 date "2014-06-01" @default.
• W2007347895 modified "2023-10-17" @default.
• W2007347895 title "Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation" @default.
• W2007347895 cites W1527151869 @default.
• W2007347895 cites W1966832647 @default.
• W2007347895 cites W1978837196 @default.
• W2007347895 cites W1984948932 @default.
• W2007347895 cites W1989327660 @default.
• W2007347895 cites W1994934232 @default.
• W2007347895 cites W1997424304 @default.
• W2007347895 cites W2000381333 @default.
• W2007347895 cites W2003367581 @default.
• W2007347895 cites W2003392370 @default.
• W2007347895 cites W2003474213 @default.
• W2007347895 cites W2006036339 @default.
• W2007347895 cites W2010427092 @default.
• W2007347895 cites W2020785408 @default.
• W2007347895 cites W2032517146 @default.
• W2007347895 cites W2036810329 @default.
• W2007347895 cites W2037638897 @default.
• W2007347895 cites W2047773760 @default.
• W2007347895 cites W2048412668 @default.
• W2007347895 cites W2060155676 @default.
• W2007347895 cites W2061388116 @default.
• W2007347895 cites W2075181486 @default.
• W2007347895 cites W2079022594 @default.
• W2007347895 cites W2095773201 @default.
• W2007347895 cites W2104305790 @default.
• W2007347895 cites W2107676800 @default.
• W2007347895 cites W2115228176 @default.
• W2007347895 cites W2129733029 @default.
• W2007347895 cites W2139508704 @default.
• W2007347895 cites W2148926898 @default.
• W2007347895 cites W2150433337 @default.
• W2007347895 cites W2153409108 @default.
• W2007347895 doi "https://doi.org/10.1016/j.biomaterials.2014.02.036" @default.
• W2007347895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24680663" @default.
• W2007347895 hasPublicationYear "2014" @default.
• W2007347895 type Work @default.
• W2007347895 sameAs 2007347895 @default.
• W2007347895 citedByCount "108" @default.
• W2007347895 countsByYear W20073478952014 @default.
• W2007347895 countsByYear W20073478952015 @default.
• W2007347895 countsByYear W20073478952016 @default.
• W2007347895 countsByYear W20073478952017 @default.
• W2007347895 countsByYear W20073478952018 @default.
• W2007347895 countsByYear W20073478952019 @default.
• W2007347895 countsByYear W20073478952020 @default.
• W2007347895 countsByYear W20073478952021 @default.
• W2007347895 countsByYear W20073478952022 @default.
• W2007347895 countsByYear W20073478952023 @default.
• W2007347895 crossrefType "journal-article" @default.
• W2007347895 hasAuthorship W2007347895A5006996556 @default.
• W2007347895 hasAuthorship W2007347895A5023209304 @default.
• W2007347895 hasAuthorship W2007347895A5025996303 @default.
• W2007347895 hasAuthorship W2007347895A5028584083 @default.
• W2007347895 hasAuthorship W2007347895A5033244066 @default.
• W2007347895 hasAuthorship W2007347895A5045109662 @default.
• W2007347895 hasAuthorship W2007347895A5051430265 @default.
• W2007347895 hasAuthorship W2007347895A5053798680 @default.
• W2007347895 hasAuthorship W2007347895A5060185042 @default.
• W2007347895 hasAuthorship W2007347895A5079540565 @default.
• W2007347895 hasAuthorship W2007347895A5083636323 @default.
• W2007347895 hasAuthorship W2007347895A5086874263 @default.
• W2007347895 hasAuthorship W2007347895A5090257305 @default.
• W2007347895 hasConcept C126322002 @default.
• W2007347895 hasConcept C126838900 @default.
• W2007347895 hasConcept C136229726 @default.
• W2007347895 hasConcept C143753070 @default.
• W2007347895 hasConcept C150903083 @default.
• W2007347895 hasConcept C155672457 @default.
• W2007347895 hasConcept C171250308 @default.
• W2007347895 hasConcept C185592680 @default.
• W2007347895 hasConcept C192562407 @default.
• W2007347895 hasConcept C202751555 @default.
• W2007347895 hasConcept C207001950 @default.
• W2007347895 hasConcept C2778902805 @default.
• W2007347895 hasConcept C2779820397 @default.
• W2007347895 hasConcept C2780165375 @default.
• W2007347895 hasConcept C502942594 @default.
• W2007347895 hasConcept C55493867 @default.
• W2007347895 hasConcept C71924100 @default.
• W2007347895 hasConcept C86803240 @default.

• next